Adipokines

• The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.
  (Gualillo O, et.al. Trends Cardiovasc Med. 2007 Nov;17(8):275-83.)
  View Abstract 

Adipose Tissue Disorders

• Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis.
  (Gustafson B, et.al. Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2276-83. Epub 2007 Sep 6. Review.)
  View Abstract 

Cancer

• Adiposity, the metabolic syndrome, and breast cancer in African-American and White American Women.
  (Rose DP, et.al. Endocr Rev. 2007 Nov 2; [Epub ahead of print])
  View Abstract

Cardiovascular Disease

• Cardiovascular risk in the metabolic syndrome: fact or fiction?
  (Nilsson PM. Curr Cardiol Rep. 2007 Nov;9(6):479-85.)
  View Abstract
• Cardiovascular morbidity and mortality of the metabolic syndrome.
  (Obunai K, et.al. Med Clin North Am. 2007 Nov;91(6):1169-84.)
  View Abstract
• Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome.
  (Salas-Salvadó J, et.al. Metabolism. 2007 Nov;56(11):1486-92.)
  View Abstract 

• Metabolic syndrome, cardiovascular disease and type-2 diabetes.
  (Bano KA, et.al. J Pak Med Assoc. 2007 Oct;57(10):511-5.)
  View Abstract
• Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction.
  (Tartan Z, et.al. Nutr Metab Cardiovasc Dis. 2007 Nov 1; [Epub ahead of print])
  View Abstract
• Impact of metabolic syndrome on clinical and angiographic outcome after sirolimus-eluting stent implantation.
  (Stellbrink E, et.al. Coron Artery Dis. 2007 Dec;18(8):601-6.)
  View Abstract
• Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease.
  (Satoh M, et.al. Atherosclerosis. 2007 Nov 3; [Epub ahead of print])
  View Abstract
• Preventing type 2 diabetes and cardiovascular disease in metabolic syndrome: the role of PPARalpha.
  (Plutzky J.Diab Vasc Dis Res. 2007 Sep;4 Suppl 3:S12-4.)
  View Abstract
• Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence.
  (Preiss D, et.al. Heart. 2007 Dec;93(12):1493-6.)
  View Abstract
• Metabolic syndrome, cardiovascular disease and type-2 diabetes.
  (Bano KA, et.al. J Pak Med Assoc. 2007 Oct;57(10):511-5.)
  View Abstract
• Regulation of the Na,K-ATPase: Special implications for cardiovascular complications of metabolic syndrome.
  (Chibalin AV.Pathophysiology. 2007 Oct 29; [Epub ahead of print])
  View Abstract
• The metabolic syndrome and cerebrovascular disease: suspicion and evidence.
  (Gil-Núñez A.Cerebrovasc Dis. 2007;24 Suppl 1:64-75. Epub 2007 Nov 1.)
  View Abstract
• Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease.
  (Hardie DG.FEBS Lett. 2007 Nov 21; [Epub ahead of print])
  View Abstract
• Carotid atherosclerosis in normal-weight metabolic syndrome.
  (Kawamoto R, et.al. Intern Med. 2007;46(21):1771-7. Epub 2007 Nov 1.)
  View Abstract

Diabetes

• Testosterone, diabetes mellitus, and the metabolic syndrome.
  (Spark RF.Curr Urol Rep. 2007 Nov;8(6):467-71.)
  View Abstract
• High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study.
  (Stengel B, et.al. Diabetes Metab. 2007 Nov 12; [Epub ahead of print])
  View Abstract
• Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: A community-based study.
  (Hsu PF, et.al. Diabetes Res Clin Pract. 2007 Nov 12; [Epub ahead of print])
  View Abstract
• Impaired early insulin secretion in Japanese type 2 diabetes with metabolic syndrome.
  (Fukuda-Akita E, et.al. Diabetes Res Clin Pract. 2007 Nov 12; [Epub ahead of print])
  View Abstract
• The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius.
  (Cameron AJ, et.al. Diabet Med. 2007 Dec;24(12):1460-9. Epub 2007 Nov 1.)
  View Abstract
• Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
  (Cull CA, et.al. Circulation. 2007 Nov 6;116(19):2119-26. Epub 2007 Oct 22.)
  View Abstract
• Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?
  (Joffe D, et.al. Med Clin North Am. 2007 Nov;91(6):1107-23.)
  View Abstract
• Prevention of diabetes development in those with the metabolic syndrome.
  (Tupper T, et.al. Med Clin North Am. 2007 Nov;91(6):1091-105.)
  View Abstract
• The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study.
  (Hunt KJ, et.al. Ann Epidemiol. 2007 Nov;17(11):870-7. Epub 2007 Jul 27.)
  View Abstract
• A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults.
  (Unwin N, et.al. Ethn Dis. 2007 Summer;17(3):522-8.)
  View Abstract
• Does the prevalence of the metabolic syndrome improve by applying the International Diabetes Federation criteria?
  (Soto González A, et.al. Public Health Nutr. 2007 Oct;10(10A):1173-80.)
  View Abstract
• Metabolic syndrome and type 2 diabetes: lipid and physiological consequences.
  (Chapman MJ.Diab Vasc Dis Res. 2007 Sep;4 Suppl 3:S5-8.)
  View Abstract

Diet, Nutrition and Metabolism

• Erythrocyte Fatty Acid Composition and the Metabolic Syndrome: A National Heart, Lung, and Blood Institute GOLDN Study.
  (Kabagambe EK, et.al. Clin Chem. 2007 Nov 12; [Epub ahead of print])
  View Abstract
• Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels.
  (Ng TW, et.al. Diabetes Care. 2007 Nov;30(11):2945-50. Epub 2007 Aug 8.)
  View Abstract
• Is metabolic syndrome X a disorder of the brain with the initiation of low-grade systemic inflammatory events during the perinatal period?
  (Das UN.J Nutr Biochem. 2007 Nov;18(11):701-13. Epub 2007 May 2.)
  View Abstract 

• Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats.
  (Wu G, et.al. J Nutr. 2007 Dec;137(12):2680-5.)
  View Abstract
• Modifying soul food for the Dietary Approaches to Stop Hypertension diet (DASH) plan: implications for metabolic syndrome (DASH of Soul).
  (Rankins J, et.al. Ethn Dis. 2007 Summer;17(3 Suppl 4):S4-7-12.)
  View Abstract
• Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
  (Ooi EM, et.al. Asia Pac J Clin Nutr. 2007;16(4):624-31.)
  View Abstract

Drug Therapy

• Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents.
  (Hoffmann R, et.al. Am J Cardiol. 2007 Nov 1;100(9):1347-52. Epub 2007 Aug 9.)
  View Abstract
• Should we have more definitions of metabolic syndrome or simply take waist measurement?
  (Bauduceau B, et.al. Diabetes Metab. 2007 Nov;33(5):333-9. Epub 2007 Jul 3.)
  View Abstract 

• Inter-organ metabolic communication involved in energy homeostasis: Potential therapeutic targets for obesity and metabolic syndrome.
  (Yamada T, et.al. Pharmacol Ther. 2007 Oct 13; [Epub ahead of print])
  View Abstract
• Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
  (Winkler K, et.al. Clin Ther. 2007 Sep;29(9):1987-2000.)
  View Abstract
• Dose-Dependent Regulation of High-Density Lipoprotein Metabolism with Rosuvastatin in the Metabolic Syndrome.
  (Ooi EM, et.al. J Clin Endocrinol Metab. 2007 Nov 20; [Epub ahead of print])
  View Abstract
• The Effect of NeOpuntia(R) on Blood Lipid Parameters-Risk Factors for the Metabolic Syndrome (Syndrome X).
  (Linarès E, et.al. Adv Ther. 2007 Sep-Oct;24(5):1115-25.)
  View Abstract

Epidemiology

• Relationship between indices of iron status and coronary risk factors including diabetes and the metabolic syndrome in Saudi subjects without overt coronary disease.
  (Alissa EM, et.al. J Trace Elem Med Biol. 2007;21(4):242-54. Epub 2007 Aug 7.)
  View Abstract
• Prevalence of Metabolic Syndrome and Associated Risk Factors in Asian Indians.
  (Balasubramanyam A, et.al. J Immigr Minor Health. 2007 Nov 16; [Epub ahead of print])
  View Abstract
• High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome.
  (Zhao Z, et.al. Metabolism. 2007 Dec;56(12):1612-9.)
  View Abstract
• Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
  (Zanchetti A, et.al. J Hypertens. 2007 Dec;25(12):2463-2470.)
  View Abstract
• Prevalence of metabolic syndrome compared between native Japanese and Japanese-Americans.
  (Yoneda M, et.al. Diabetes Res Clin Pract. 2007 Nov 13; [Epub ahead of print])
  View Abstract
• Metabolic syndrome in the Hong Kong community: the United Christian Nethersole Community Health Service primary healthcare programme 2001-2002.
  (Ko GT, et.al. Singapore Med J. 2007 Dec;48(12):1111-6.)
  View Abstract
• Metabolic syndrome determinants in an urban population from Brazil: Social class and gender-specific interaction.
  (Marquezine GF, et.al. Int J Cardiol. 2007 Nov 22; [Epub ahead of print])
  View Abstract
• Components of the Metabolic Syndrome Predictive of its Development: A Six Year Longitudinal Study in Hong Kong Chinese.
  (Cheung BM, et.al. Clin Endocrinol (Oxf). 2007 Nov 2; [Epub ahead of print])
  View Abstract
• Gender-associated differences in metabolic syndrome-related parameters in Göttingen minipigs.
  (Christoffersen BO, et.al. Comp Med. 2007 Oct;57(5):493-504.)
  View Abstract
• 25-hydroxyvitamin D, insulin-like growth factor 1 and metabolic syndrome at age 45y: a cross-sectional study in the 1958 British birth cohort.
  (Hyppönen E, et.al. Diabetes. 2007 Nov 14; [Epub ahead of print])
  View Abstract
• The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic Taiwanese.
  (Lee IT, et.al. Metabolism. 2007 Dec;56(12):1708-13.)
  View Abstract

Exercise / Physical Activity

• Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease.
  (Hamilton MT, et.al. Diabetes. 2007 Nov;56(11):2655-67. Epub 2007 Sep 7.)
  View Abstract 

• Sedentary behaviour, physical activity and a continuous metabolic syndrome risk score in adults.
  (Wijndaele K, et.al. Eur J Clin Nutr. 2007 Oct 31; [Epub ahead of print])
  View Abstract
• The effect of leisure-time physical activity on the presence of metabolic syndrome in patients with manifest arterial disease. The SMART study.
  (Brouwer BG, et.al. Am Heart J. 2007 Dec;154(6):1146-52. Epub 2007 Sep 12.)
  View Abstract

Genetics

• Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome.
  (González-Sánchez JL, et.al. Clin Endocrinol (Oxf). 2007 Nov 6; [Epub ahead of print])
  View Abstract
• PPAR Agonists and the Metabolic Syndrome.
  (Staels B.Therapie. 2007 Juillet-Aout;62(4):319-326. Epub 2007 Nov 6.)
  View Abstract
• Prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism and parameters of the metabolic syndrome.
  (Lindner I, et.al. Mol Nutr Food Res. 2007 Nov 2; [Epub ahead of print])
  View Abstract
• Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes.
  (Junien C, et.al. Obes Rev. 2007 Nov;8(6):487-502.)
  View Abstract 

• The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes.
  (Comuzzie AG, et.al. Hum Biol. 2007 Apr;79(2):191-200.)
  View Abstract

Hypertension

• Metabolic and clinical outcomes in non-diabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as Initial treatment for hypertension: A report from the ALLHAT study.
  (Black HR, et.al. Diabetes Care. 2007 Nov 13; [Epub ahead of print])
  View Abstract
• Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function.
  (Mulè G, et.al. J Hum Hypertens. 2007 Nov;21(11):854-60. Epub 2007 May 31.)
  View Abstract
• Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
  (Suzuki T, et.al. Med Clin North Am. 2007 Nov;91(6):1211-23.)
  View Abstract
• Pulse pressure amplification, adiposity and metabolic syndrome in subjects under chronic antihypertensive therapy: The role of heart rate.
  (Vergnaud AC, et.al. Atherosclerosis. 2007 Nov 5; [Epub ahead of print])
  View Abstract 

• Nocturnal blood pressure fall and metabolic syndrome score in hypertensive patients.
  (Vyssoulis GP, et.al. Blood Press Monit. 2007 Dec;12(6):351-6.)
  View Abstract
• Antihypertensive efficacy of zofenopril plus hydrochlorothiazide fixed combination for treatment in metabolic syndrome.
  (Malacco E, et.al. Adv Ther. 2007 Sep-Oct;24(5):1006-15.)
  View Abstract

Insulin Sensitivity / Insulin Resistance

• Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome.
  (Kotronen A, et.al. Diabetologia. 2007 Nov 16; [Epub ahead of print])
  View Abstract
• Insulin resistance as the underlying cause for the metabolic syndrome.
  (Lann D, et.al. Med Clin North Am. 2007 Nov;91(6):1063-77.)
  View Abstract
• High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
  (Seino Y, et.al. Metabolism. 2007 Nov;56(11):1493-9.)
  View Abstract
• Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Bertoni AG, et.al. Diabetes Care. 2007 Nov;30(11):2951-6. Epub 2007 Aug 17.)
  View Abstract

• Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome.
  (Sniderman AD, et.al. Curr Opin Lipidol. 2007 Dec;18(6):633-7.)
  View Abstract

Metabolic Syndrome in Women

• Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena.
  (Gentile M, et.al. Clin Chim Acta. 2007 Nov 6; [Epub ahead of print])
  View Abstract
• Educational and organizational interventions used to improve the knowledge of metabolic syndrome among postmenopausal women.
  (Barriga J, et.al. Fertil Steril. 2007 Nov 1; [Epub ahead of print])
  View Abstract
• Effect of age, degree and distribution of adiposity on the prevalence of the metabolic syndrome in a cohort of obese Italian women.
  (Sartorio A, et.al. Diabetes Res Clin Pract. 2007 Nov;78(2):225-33. Epub 2007 Apr 30.)
  View Abstract 

Non-Alcoholic Fatty Liver Disease

• Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in thai subjects.
  (Liu Y, et.al. J Clin Endocrinol Metab. 2007 Nov;92(11):4313-8. Epub 2007 Aug 14.)
  View Abstract 

• Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
  (Hsiao PJ, et.al. J Gastroenterol Hepatol. 2007 Dec;22(12):2118-23.)
  View Abstract

Obesity

• Prevalence of obesity and metabolic syndrome in Korean adults.
  (Park HS, et.al. Obes Rev. 2007 Nov 6; [Epub ahead of print])
  View Abstract
• Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity.
  (Calcaterra V, et.al. Clin Endocrinol (Oxf). 2007 Nov 2; [Epub ahead of print])
  View Abstract
• Bariatric surgery for morbid obesity-a cure for metabolic syndrome?
  (Kini S, et.al. Med Clin North Am. 2007 Nov;91(6):1255-71.)
  View Abstract
• Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children.
  (Aeberli I, et.al. J Clin Endocrinol Metab. 2007 Nov;92(11):4359-65. Epub 2007 Aug 28.)
  View Abstract 
• Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome.
  (Deushi M, et.al. FEBS Lett. 2007 Nov 21; [Epub ahead of print])
  View Abstract 
• Measuring Visceral Fat with Water-Selective Suppression Methods (SPIR, SPAIR) in Patients with Metabolic Syndrome.
  (Tanaka S, et.al. Magn Reson Med Sci. 2007;6(3):171-5.)
  View Abstract

Other

• Psoriasis and the metabolic syndrome.
  (Cohen AD, et.al. Acta Derm Venereol. 2007;87(6):506-9.)
  View Abstract
• The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients.
  (Coll B, et.al. Atherosclerosis. 2007 Nov 3; [Epub ahead of print])
  View Abstract
• Linkage between oxygen uptake at ventilatory threshold and muscle strength in subjects with and without metabolic syndrome.
  (Miyatake N, et.al. Acta Med Okayama. 2007 Oct;61(5):255-9.)
  View Abstract
• Metabolic syndrome as a modifier of atherosclerosis in murine models.
  (Péterfy M, et.al. Curr Drug Targets. 2007 Nov;8(11):1215-20.)
  View Abstract

Pediatrics

• Identifying and evaluating the metabolic syndrome in children and adolescents.
  (Rappaport EB. Ethn Dis. 2007 Summer;17(3 Suppl 4):S4-1-6.)
  View Abstract
• Relationship between metabolic syndrome definitions for children and adolescents and intima-media thickness.
  (Reinehr T, et.al. Atherosclerosis. 2007 Nov 20; [Epub ahead of print])
  View Abstract
• Aerobic fitness, fatness and the metabolic syndrome in children and adolescents.
  (Eisenmann JC.Acta Paediatr. 2007 Dec;96(12):1723-9. Epub 2007 Oct 30.)
  View Abstract
• Diagnostic criteria patterns of U.S. children with Metabolic Syndrome: NHANES 1999-2002.
  (Kranz S, et.al. Nutr J. 2007 Nov 6;6(1):38 [Epub ahead of print])
  View Abstract
• Metabolic syndrome in childhood.
  (Crespo PS, et.al. Public Health Nutr. 2007 Oct;10(10A):1121-5.)
  View Abstract
• Correlation between white blood cell count and metabolic syndrome in adolescence.
  (Hsieh CH, et.al. Pediatr Int. 2007 Dec;49(6):827-32.)
  View Abstract

Prevention

• The metabolic syndrome - a global challenge for prevention.
  (Schwarz PE, et.al. Horm Metab Res. 2007 Nov;39(11):777-80.)
  View Abstract

Psychiatric Disorders

• Body mass index as a screening test for metabolic syndrome in schizophrenia and schizoaffective disorders.
  (Tirupati S, et.al. Australas Psychiatry. 2007 Dec;15(6):470-3.)
  View Abstract
• Planning for the optimal design of studies to personalize antipsychotic prescriptions in the post-CATIE era: the clinical and pharmacoepidemiological data suggest that pursuing the pharmacogenetics of metabolic syndrome complications (hypertension, diabetes mellitus and hyperlipidemia) may be a reasonable strategy.
  (de Leon J, et.al. Schizophr Res. 2007 Nov;96(1-3):185-97. Epub 2007 Jul 6.)
  View Abstract
• Prevalence of the metabolic syndrome among schizophrenic patients hospitalized in the Canary Islands.
  (Sánchez-Araña T, et.al. Actas Esp Psiquiatr. 2007 Nov-Dec;35(6):359-67.)
  View Abstract
• Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.
  (Ellingrod VL, et.al. Schizophr Res. 2007 Oct 30; [Epub ahead of print])
  View Abstract
• Weight gain, dyslipidemia and altered parameters for metabolic syndrome on first episode psychotic patients after six-month follow- up.
  (Attux C, et.al. Rev Bras Psiquiatr. 2007 Oct 31; [Epub ahead of print])
  View Abstract

Renal Function / Kidney Disease

• Identifying Patients with Type 2 Diabetes at High Risk of Microalbuminuria: Results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study.
  (Rossi MC, et.al. Nephrol Dial Transplant. 2007 Nov 26; [Epub ahead of print])
  View Abstract
• Plasma Fatty Acid-Binding Protein 4 Increases with Renal Dysfunction in Type 2 Diabetic Patients without Microalbuminuria.
  (Cabré A, et.al. Clin Chem. 2007 Nov 16; [Epub ahead of print])
  View Abstract
• Weight reduction in renal transplant recipients program: the first successes.
  (Jezior D, et.al. Transplant Proc. 2007 Nov;39(9):2769-71.)
  View Abstract
• A lack of increase in high molecular weight-adiponectin in macroalbuminuric subjects with metabolic syndrome may exert renal and atherosclerotic risks.
  (Tsuda SI, et.al. Diabetes Res Clin Pract. 2007 Nov 13; [Epub ahead of print])
  View Abstract
• Renal manifestations of metabolic syndrome in type 2 diabetes.
  (Hanai K, et.al. Diabetes Res Clin Pract. 2007 Nov 3; [Epub ahead of print])
  View Abstract

Risk Factors

• Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome.
  (Oka R, et.al. Diabetes Res Clin Pract. 2007 Nov 19; [Epub ahead of print])
  View Abstract
• Prevalence of Metabolic Syndrome and Associated Risk Factors in Asian Indians.
  (Balasubramanyam A, et.al. J Immigr Minor Health. 2007 Nov 16; [Epub ahead of print])
  View Abstract
• Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature.
  (Goldbacher EM, et.al. Ann Behav Med. 2007 Nov-Dec;34(3):240-52.)
  View Abstract
• The metabolic syndrome and the risk of arterial and venous thrombosis.
  (Franchini M, et.al. Thromb Res. 2007 Nov 7; [Epub ahead of print])
  View Abstract
• Microalbuminuria Accounts for the Increased Vascular Disease Risk in Diabetic Patients With Metabolic Syndrome.
  (Gimeno-Orna JA, et.al. Rev Esp Cardiol. 2007 Nov;60(11):1202-1205. English, Spanish.)
  View Abstract
• The risk of metabolic syndrome according to the high-sensitivity C-reactive protein in apparently healthy Koreans.
  (Jung CH, et.al. Int J Cardiol. 2007 Nov 5; [Epub ahead of print])
  View Abstract
• Aerobic fitness attenuates the metabolic syndrome score in normal-weight, at-risk-for-overweight, and overweight children.
  (DuBose KD, et.al. Pediatrics. 2007 Nov;120(5):e1262-8.)
  View Abstract
• Macrovascular disease in a Japanese-Brazilian population of high prevalence of metabolic syndrome: associations with classical and non-classical risk factors.
  (Siqueira AF, et.al. Atherosclerosis. 2007 Nov;195(1):160-6. Epub 2006 Oct 24.)
  View Abstract
• Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.
  (Kuller LH, et.al. Atherosclerosis. 2007 Nov;195(1):122-8. Epub 2006 Oct 2.)
  View Abstract

Sleep Disorders

• An update on obstructive sleep apnea and the metabolic syndrome.
  (Lam JC, et.al. Curr Opin Pulm Med. 2007 Nov;13(6):484-9.)
  View Abstract